Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that FOXP3+ regulatory T cells suppress effector T cells via COX-2-dependent mechanisms, suggesting potential therapeutic targets.
CD4+CD25+ regulatory T (T(R)) cells suppress effector T cells by partly unknown mechanisms. In this study, we describe a population of human suppressive CD4+CD25+ adaptive T(R) (T(R)(adapt)) cells induced in vitro that express cyclooxygenase 2 (COX-2) and the transcription factor FOXP3. T(R)(adapt) cells produce PGE(2) and suppress effector T cell responses in a manner that is reversed by COX inhibitors and PGE(2) receptor-specific antagonists. In resting CD4+CD25- T cells, treatment with PGE(2) induced FOXP3 expression. Thus, autocrine and paracrine effects of PGE(2) produced by COX-2-positive T(R)(adapt) cells may be responsible for both the FOXP3+ phenotype and the mechanism used by these cells to suppress effector T cells.
No takes yet. Share an insight, caveat, or question.
Mahic et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: